Whitney & Co’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.5M | Buy |
43,809
+14
| +0% | +$6.23K | 1.92% | 15 |
|
|
2025
Q1 | $21.2M | Buy |
43,795
+549
| +1% | +$266K | 2.26% | 11 |
|
|
2024
Q4 | $17.4M | Sell |
43,246
-160
| -0.4% | -$64.4K | 1.83% | 16 |
|
|
2024
Q3 | $20.2M | Sell |
43,406
-7,748
| -15% | -$3.6M | 2.16% | 10 |
|
|
2024
Q2 | $24M | Buy |
51,154
+596
| +1% | +$279K | 2.75% | 7 |
|
|
2024
Q1 | $21.1M | Buy |
50,558
+530
| +1% | +$222K | 2.52% | 9 |
|
|
2023
Q4 | $20.4M | Buy |
50,028
+93
| +0.2% | +$37.8K | 2.63% | 6 |
|
|
2023
Q3 | $17.4M | Buy |
49,935
+405
| +0.8% | +$141K | 2.61% | 8 |
|
|
2023
Q2 | $17.4M | Sell |
49,530
-5,272
| -10% | -$1.86M | 2.51% | 6 |
|
|
2023
Q1 | $17.3M | Buy |
54,802
+1,940
| +4% | +$611K | 2.74% | 4 |
|
|
2022
Q4 | $15.3M | Buy |
52,862
+643
| +1% | +$186K | 2.8% | 7 |
|
|
2022
Q3 | $15.1M | Buy |
52,219
+384
| +0.7% | +$111K | 2.94% | 6 |
|
|
2022
Q2 | $14.6M | Buy |
51,835
+311
| +0.6% | +$87.6K | 2.66% | 6 |
|
|
2022
Q1 | $13.4M | Buy |
51,524
+1,389
| +3% | +$362K | 2.07% | 13 |
|
|
2021
Q4 | $11M | Buy |
50,135
+733
| +1% | +$161K | 1.62% | 19 |
|
|
2021
Q3 | $8.96M | Buy |
49,402
+3,509
| +8% | +$636K | 1.43% | 27 |
|
|
2021
Q2 | $9.25M | Buy |
+45,893
| New | +$9.25M | 1.48% | 29 |
|